This is the story of a mother who was diagnosed with cancer while two months pregnant. She had already undergone breast surgery and was supposed to have a hysterectomy and chemotherapy but canceled the procedures after discovering ECCT.
Photo of Mrs. Nurhayati when she reached 5 years as a survivor (2019), and 10 years (2024), with her children.
In mid-2013, Mrs. Nurhayati was pregnant with her first child. She was only two months into her pregnancy when a doctor diagnosed her with cancer. She then underwent a mastectomy. The results of the anatomical pathology (cell examination) showed an aggressive form of cancer (Non-Special Type (NST), Grade 3). Therefore, she was advised to undergo a series of chemotherapy sessions.
But that wasn’t the end of her ordeal. In addition to chemotherapy after breast surgery, she was also advised to undergo a hysterectomy, which would mean terminating her pregnancy. There was no other option—the medical procedure was set in stone.
She and her husband faced a difficult dilemma. Not only did she have to race against time to battle a highly malignant cancer that threatened her life, but she was also forced to sacrifice the baby growing inside her, their first child.
Amidst this heavy dilemma, she learned about ECCT, an electrical therapy using extremely low voltage powered by a battery similar to the one used in a TV remote control. It was the most viable alternative that would allow her to treat her cancer while keeping her baby, without undergoing chemotherapy.
At that time, ECCT was still in development and was mired in controversy within the medical community. Mrs. Nurhayati only trusted the story of Mrs. Suwarni, the first person to use the ECCT device developed by her brother. Mrs. Suwarni had also undergone a mastectomy before using the ECCT device. The type of cancer Mrs. Suwarni experienced was the same, NST Grade 3. Therefore, without much hesitation, Mrs. Nurhayati and her husband decided to pursue this alternative.
Mrs. Nurhayati canceled her scheduled hysterectomy and chemotherapy appointments. She chose to fight her battle against cancer with the ECCT device while continuing her pregnancy until she gave birth.
In the early stages of using the device, the progress wasn’t promising. The results of the cell activity scan using ECVT showed increasing electrical activity, and her surgical wound did not heal until it was time for her to give birth. However, she did not stop the therapy. Eventually, Mrs. Nurhayati gave birth safely. Her surgical wound also began to heal, and several areas around the stitches that had previously shown recurrence turned black, dried up, and fell off.
One year after first using ECCT, her cancer could finally be considered cleared. This differed from Mrs. Suwarni’s case, who reached remission in just two months. The delay in Mrs. Nurhayati’s case was likely due to high hormone activity in her body caused by the pregnancy. Hormonal activity is a critical factor that generally hampers breast cancer therapy, including treatment with the ECCT device.
Afterward, Mrs. Nurhayati experienced no further complications. Her cancer never returned, without chemotherapy and without needing to terminate her pregnancy. Five years later, she gave birth to her second child, followed by a third child two years later.
Now, 10 years since her breast cancer diagnosis, she remains healthy. Her three children are also in good health. Mrs. Nurhayati still uses the ECCT device for preventive purposes.
Wishing continued health for Mrs. Nurhayati and her family. (WS)
About ECCT:
https://c-techlabs.com/electro-capacitive-cancer-therapy-ecct-devices/
